Theophylline in Rhinitis

NCT01132781 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Rhinosinusitis
Asthma
Allergic Rhinitis

Interventions

DRUG: Theophylline (Intervention Group)
DRUG: Placebo (Placebo Group)

Sponsor

University of East Anglia

Collaborators

[object Object]